Effects of Physical Activity, VO2max, and Visfatin on Relationship Between BMI and Chronic Inflammation
Liqiang Su,Shouzhi Wu,Jinmei Fu,Shunli Sun
DOI: https://doi.org/10.2147/dmso.s473266
2024-11-28
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Liqiang Su, 1, 2 Shouzhi Wu, 3 Jinmei Fu, 4 Shunli Sun 4 1 Physical Education of College, Jiangxi Normal University, Nanchang City, Jiangxi Province, People's Republic of China; 2 School of Physical Education and Sport Science, Fujian Normal University, Fuzhou City, Fujian Province, People's Republic of China; 3 School of Public Foundation, Wannan Medical College, Wuhu City, Anhui Province, People's Republic of China; 4 Jiangxi Sports Science Medical Center, Nanchang City, Jiangxi Province, People's Republic of China Correspondence: Liqiang Su; Shouzhi Wu, Email ; Purpose: This study aims to explore the relationship between BMI and chronic inflammation and to investigate the interaction and mediation of physical activity (PA), cardiopulmonary function, and visfatin. Methods: A total of 119 participants were included in the study, 60 in the obesity group, 30 in the normal weight group, and 29 in the overweight group. PA, VO 2max , visfatin, high-sensitivity C-reactive protein (hs-CRP), and four blood lipid indices (TC, TG, HDLC, LDLC) were analyzed. Regression analysis was used to understand the effect of BMI on chronic inflammation. Covariate analysis was conducted to screen effective covariates affecting BMI to predict chronic inflammation and test the interaction and intermediary role of effective covariates. Results: The increase in BMI could aggravate chronic inflammation. PA, VO 2max , and visfatin had interactive effects on BMI affecting chronic inflammation, and visfatin played an intermediary role in BMI affecting chronic inflammation. The effect value of BMI on chronic inflammation in terms of low PA was 3.5 times higher than that of high PA, that of low VO 2max was 2.8 times higher than that of high VO 2max , and that of high visfatin was 3.65 times higher than that of low visfatin. Approximately 19.35% of the effect was mediated by visfatin. Conclusion: An increase in BMI can aggravate chronic inflammation. Increases in PA and VO 2max can alleviate chronic inflammation, and visfatin plays a positive mediating role. Keywords: obesity, chronic inflammation, physical activity, VO 2max , visfatin Obesity and related metabolic diseases, tumors, and other diseases have increased dramatically worldwide; 1,2 these diseases will not only reduce the quality of life of individuals but also bring a huge burden to families and society. Obesity has become a research focus of scholars. A study found that the process of individuals from normal weight to obesity was accompanied by intensification of chronic inflammation. 3 Chronic inflammation always occurs without clinical symptoms and induces many diseases. 4 To identify the risk and prognosis of obesity-related diseases, scholars use indicators, such as TNF-α and hs-CRP, as well as the intermediate or end products of chronic inflammatory reaction. 5 Chronic inflammation was found to be positively correlated with obesity. 6 It varies among people with similar BMI. In addition to BMI, many factors can affect chronic inflammation. Energy accumulation is closely related to BMI and chronic inflammation. 7 Therefore, we can identify the risk factors of chronic inflammation from multiple perspectives and explore the regulatory role of energy accumulation (PA, cardiopulmonary function, fat factor, etc.) in the relationship between BMI and chronic inflammation. Epidemiological studies show that decreased PA is associated with increased chronic inflammation. 8–10 Conversely, increased PA can alleviate chronic inflammation. 11,12 Cardiopulmonary function is negatively correlated with chronic inflammation. 13,14 Improvement of cardiopulmonary function can alleviate the aggravation of chronic inflammation. 12 Although an increase in BMI can aggravate the accumulation of chronic inflammation, 3 greater PA and cardiopulmonary function can alleviate it. However, during the development of obesity from normal weight, with the increase of BMI, the regulatory effect of different PA and cardiopulmonary function on chronic inflammation remains unclear. Studies on the regulation of chronic inflammation show that the degree of adipose tissue accumulation is significantly related to the amount of visfatin secreted by fat. 15–17 In obese people, chronic inflammation is significantly positively correlated with the level of circulating visfatin. 17 As such, visfatin can drive chronic inflammation. 18,19 Although current epidemiology literature indicates that visfatin affects chronic inflammation 15,19, the spec -Abstract Truncated-
endocrinology & metabolism